Mission and Scope

Mission:

Our mission is to facilitate timely and broad dissemination of kidney science by offering rigorous and expeditious peer review and rapid open access publication. Kidney360 is a global, peer-reviewed, open access, online only, general kidney journal that publishes scientifically rigorous basic, translational, clinical, epidemiologic, health policy, population science, and global health kidney research. 

Scope:

Kidney360 is a general interest kidney journal that includes content from all disciplines of kidney science. Kidney360 will consider a broad array of original investigations, meta-analyses, and reviews in domains including basic, translational, clinical, epidemiologic, health policy, population science, and global health research. Kidney360 will consider original investigation that contributes in a meaningful way to kidney science. Kidney360 recognizes that establishment of reproducibility across populations defined by different stages of disease or other characteristics, and presentation of robustly designed and adequately powered clinical trials with negative results can be important contributions; Kidney360 will therefore welcome submissions of manuscripts that contribute to reproducibility and manuscripts describing negative results. Kidney360 will also consider rigorous qualitative research, and research in the areas of quality improvement, patient safety, health systems performance, and health care value.

Additional Information

Frequency:

Kidney360 (Online ISSN: 2641-7650) is an official publication of the American Society of Nephrology. There is one volume and 12 issues per year beginning in January.

Indexes:

The Journal is currently indexed by the following services in print and/or electronic format:

Disclaimer:

The statements and opinions contained in the articles of Kidney360 are solely those of the individual authors and contributors and not of the American Society of Nephrology. The appearance of advertisements in the Journal is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality, or safety. The American Society of Nephrology disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements.

To avoid conflict of interest, all members of the Editorial Team have completed financial disclosure forms that are available for review in appropriate circumstances when requested from the Editor-in-Chief. 

End of the Year Newsletter: 2021

Please see the Kidney360 Editorial Board Newsletter from Dr. Michael Allon, Editor-in-Chief.